Search
Products
Community
Markets
News
Brokers
More
EN
Get started
CRISPR Therapeutics AG
Long
Apr 22, 2018
Option Sale Opportunity
2
Grab this chart
Grab this chart
1
1
CRSP is admittedly a VERY volatile name, but one with a big future and I believe a CL list stock at GS.
On Friday, I was able to sell the May $45 puts for $1.90.
If I am exercised, my cost basis will be $43.10, which puts it right in the support of the bottom of the last pullback.
I would be OK getting exercised on that and I could exit for a small loss if it violated the low of that prior pullback.
If I don't get exercised, I've earned roughly 4% of the strike price for 4 weeks exposure for a strike that is roughly 20% OTM.
I can live with that, too, as one will come close to making my monthly car payment.
Drawback: There is obviously an earnings report between now and expiration.
Add your thoughts
jhains2
Follow
Also on:
Beyond Technical Analysis
jhains2
Follow
Also on:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.